Andexxa Blood Clot Risks Lead to FDA Questions Regarding Safety of the Reversal Agent for Xarelto, Eliquis
Xarelto Side Effects More Likely to Result in Death than Warfarin for Afib Patients with Heart Disease: Study
Side Effects of Blood Thinners, Diabetes Drugs Are Leading Causes of ER Visits Due to Medications: Study
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Anticoagulant Bleeding Risk Increases with NSAID Painkiller Use: Study November 20, 2014 Irvin Jackson Add Your Comments The findings of a new study raise concerns about the use of NSAID painkillers, such as Advil, Motrin, Aleve and others common drugs, among patients who are already taking anticoagulants, such as Xarelto, Pradaxa or warfarin, suggesting that the combined use may further increase the risk of bleeding problems. Researchers from the Denmark published a study in the Annals of Internal Medicine on November 18, which found that patients being treated with blood thinners for atrial fibrillation face an increased risk of bleeding when they also use nonsteroidal anti-inflammatory drugs (NSAIDs). The study looked at data on 150,900 patients with atrial fibrillation who were prescribed an NSAID. Researchers found that within 14 days of taking NSAIDs in combination with anticoagulants, 2.5 more patients who suffered a severe bleeding event per 1,000 patients than if they had not been given an NSAID. The findings did not appear to be related to what type of NSAID or what type of blood thinner patients were given. Learn More About Xarelto Lawsuits Side Effects of Xarelto May Increase Risk of Uncontrollable Bleeding. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Xarelto Lawsuits Side Effects of Xarelto May Increase Risk of Uncontrollable Bleeding. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The findings also suggested that NSAID use increased the risk of thromboembolism events as well, such as deep vein thrombosis and pulmonary embolism. The effects appear to be dose-specific, meaning that the more NSAIDs a patient took, the more likely they were to suffer a serious bleeding event while taking the anticoagulant as well. Such dose-specific responses are generally considered a strong indicator of a causal relationship. “Use of NSAIDs was associated with increased absolute risks for serious bleeding and thromboembolism across all antithrombotic regimens and NSAID types,” the researchers determined. “An NSAID dosage above the recommended minimum was associated with a substantially increased hazard ratio for bleeding.” New Anticoagulant Bleeding Concerns The findings come amid increasing concerns about the risk of severe bleeding events associated with a new generation of anticoagulants that have been introduced in recent years as replacements for warfarin, which has been the most commonly prescribed blood thinner for atrial fibrillation patients for years. All blood thinners carry a bleeding risk, as the medications are designed to prevent clotting, which can make bleeds difficult to control. However, a new generation of blood thinners have been widely adopted in recent years, including Xarelto, Pradaxa, and Eliquis. Unlike warfarin, which can be quickly reversed with a dose of vitamin K and fresh frozen plasma in the event the bleeding develops, allowing blood to clot, there is no approved reversal agent for Xarelto, Pradaxa or Eliquis, which often leaves doctors unable to control bleeding problems, potentially increasing the risk of more serious injury or death. When Pradaxa was first released it quickly became associated with a high number of adverse event reports to the FDA and hundreds of bleeding deaths in the U.S. alone. More than 4,000 Pradaxa lawsuits were ultimately filed against Boehringer Ingelheim, alleging that the drug maker failed to adequately research the medication and withheld proper warnings about the bleeding risk and lack of a reversal agent. Following several years of litigation, the drug maker agreed to pay $650 million in Pradaxa settlements earlier this year, with an average of about $150,000 paid to resolve claims brought on behalf of former users who experienced injuries from uncontrollable bleeds. As concerns about the safety of Pradaxa mounted, Xarelto has grown to become the most widely used of the new-generation anticoagulants. However, similar reports of Xarelto bleeding problems have surfaced, with users experiencing uncontrollable gastrointestinal hemorrhaging and death. Bayer Healthcare and Johnson & Johnson’s Janssen subsidiary now face a growing number of Xarelto lawsuits, which raise similar allegations to those presented in the Pradaxa. Many of the claims indicate that the drug makers failed to adequately explore all potential reversal agents, suggesting that Xarelto should be removed from the market until a safe and effective antidote for bleeding problems is identified. Tags: Advil, Aleve, Blood Thinners, Celebrex, Eliquis, Motrin, NSAID, Pradaxa, Warfarin, Xarelto More Xarelto Lawsuit Stories Andexxa Blood Clot Risks Lead to FDA Questions Regarding Safety of the Reversal Agent for Xarelto, Eliquis November 21, 2024 Xarelto Side Effects More Likely to Result in Death than Warfarin for Afib Patients with Heart Disease: Study September 1, 2022 Side Effects of Blood Thinners, Diabetes Drugs Are Leading Causes of ER Visits Due to Medications: Study October 15, 2021 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Depo-Provera Lawsuit Pre-Settlement Funding and Loans Must Be Disclosed Under Court Order (Posted: today) A U.S. District Judge has ordered women involved in Depo-Provera lawsuits to inform him of any third-party pre-settlement loans they take out, as predatory interest rates may force them to reject settlement offers. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (07/02/2025)Lawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)Ortho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025) Judge Extends Deadlines in PFAS Lawsuits Over Liver Cancer, Thyroid Cancer (Posted: today) A federal judge has extended deadlines for parties involved in firefighting foam lawsuits to complete discovery and expert reports on liver and thyroid cancer injuries. MORE ABOUT: AFFF LAWSUITPFAS Exposure During Pregnancy Linked to High Blood Pressure in Children: Study (06/26/2025)PFAS Drinking Water Lawsuit Filed by 16 Plaintiffs Over Testicular Cancer, Kidney Cancer, Ulcerative Colitis Side Effects (06/23/2025)AFFF Chemicals May Accelerate Spread of Cancer, Reduce Drug Effectiveness: Study (06/13/2025) Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: yesterday) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025)
Andexxa Blood Clot Risks Lead to FDA Questions Regarding Safety of the Reversal Agent for Xarelto, Eliquis November 21, 2024
Xarelto Side Effects More Likely to Result in Death than Warfarin for Afib Patients with Heart Disease: Study September 1, 2022
Side Effects of Blood Thinners, Diabetes Drugs Are Leading Causes of ER Visits Due to Medications: Study October 15, 2021
Depo-Provera Lawsuit Pre-Settlement Funding and Loans Must Be Disclosed Under Court Order (Posted: today) A U.S. District Judge has ordered women involved in Depo-Provera lawsuits to inform him of any third-party pre-settlement loans they take out, as predatory interest rates may force them to reject settlement offers. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (07/02/2025)Lawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)Ortho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)
Judge Extends Deadlines in PFAS Lawsuits Over Liver Cancer, Thyroid Cancer (Posted: today) A federal judge has extended deadlines for parties involved in firefighting foam lawsuits to complete discovery and expert reports on liver and thyroid cancer injuries. MORE ABOUT: AFFF LAWSUITPFAS Exposure During Pregnancy Linked to High Blood Pressure in Children: Study (06/26/2025)PFAS Drinking Water Lawsuit Filed by 16 Plaintiffs Over Testicular Cancer, Kidney Cancer, Ulcerative Colitis Side Effects (06/23/2025)AFFF Chemicals May Accelerate Spread of Cancer, Reduce Drug Effectiveness: Study (06/13/2025)
Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: yesterday) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025)